ADRIAMYCIN Side Effects

5674046-X | Dehydration, Diarrhoea, Dizziness, Head Injury, Laceration, Loss Of Consciousness, Nausea
on Mar 19, 2008 Female patient from UNITED STATES , weighting 129.6 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriamycin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, dizziness (What is dizziness?), head injury, laceration, loss of consciousness, nausea (What is nausea?). Adriamycin dosage: 60mg/m2 Every 2 Wks Iv. During the same period patient was treated with CYTOXAN (600mg/m2 Every 2 Wks Iv) (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

5646489-1 | Breast Cancer In Situ, Metastasis
Patient was taking Adriamycin (View Usage). Patient had the following side effects: breast cancer in situ, metastasis on Feb 28, 2008 from UNITED STATES Additional patient health information: Female patient , 50 years of age, . Adriamycin dosage: . During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), TAXOL (View Taxol Review and Taxol Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ), LETROZOLE (View Letrozole Review and Letrozole Label ).

5095513-6 | Asthma, Cardiomyopathy, Pericardial Effusion, Pleural Effusion
Adverse event was reported on Aug 31, 2006 by a Female patient taking Adriamycin (View Usage) (Dosage: 6 Wks Ago) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 41 years of age, weighting 215.6 lb, After Adriamycin was administered, patient had the following side effects: asthma (What is asthma?), cardiomyopathy (What is cardiomyopathy?), pericardial effusion, pleural effusion. During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5029139-7 | Dehydration, Diarrhoea, Malaise, Nausea
on Jun 15, 2006 Female patient from UNITED STATES , 52 years of age, weighting 200.2 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriamycin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, malaise, nausea (What is nausea?). Adriamycin dosage: 117 Mg Every 2 Weeks Iv. During the same period patient was treated with CYTOXAN (1170 Mg Every 2 Weeks Iv) (View Cytoxan Review and Cytoxan Label ), ATIVAN (View Ativan Review and Ativan Label ), COMPAZINE (View Compazine Review and Compazine Label ), DECADRON (View Decadron Review and Decadron Label ), NEULASTA (View Neulasta Review and Neulasta Label ), ZOFRAN (View Zofran Review and Zofran Label ), REGLAN (View Reglan Review and Reglan Label ). Patient was hospitalized.


5028600-9 | Dyspnoea, Ejection Fraction Decreased, Nocturnal Dyspnoea, Pericardial Effusion
on Jun 15, 2006 Female patient from UNITED STATES , 53 years of age, weighting 138.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriamycin (View Usage). Patient had the following side effects: dyspnoea, ejection fraction decreased, nocturnal dyspnoea, pericardial effusion. Adriamycin dosage: . During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VICODIN (View Vicodin Review and Vicodin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ), AMBIEN (View Ambien Review and Ambien Label ), VITAMIN (View Vitamin Review and Vitamin Label ). Patient was hospitalized.

4850810-1 | Blood Creatinine Increased, Cystitis
Patient was taking Adriamycin (View Usage). After Adriamycin was administered, patient had the following side effects: blood creatinine increased, cystitis on Dec 08, 2005 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 161.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Adriamycin dosage: 108 Mg Iv. During the same period patient was treated with CYTOXAN (1080 Mg Iv) (View Cytoxan Review and Cytoxan Label ), GCSF (View Gcsf Review and Gcsf Label ), SCOPOLAMIN PATCH (View Scopolamin Patch Review and Scopolamin Patch Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4724335-8 | Abdominal Pain, Body Temperature Increased, Disease Recurrence, Diverticulitis
Adverse event was reported on Jul 20, 2005 by a Female patient taking Adriamycin (View Usage) (Dosage: 80mg Q 21 D Iv) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 56 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), body temperature increased, disease recurrence, diverticulitis. During the same period patient was treated with CYTOXAN (1300mg Q 21d Iv) (View Cytoxan Review and Cytoxan Label ), TAXOTERE (122mg Q 21 Iv) (View Taxotere Review and Taxotere Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), TYLOX (View Tylox Review and Tylox Label ), COUMADIN (View Coumadin Review and Coumadin Label ), VALTREX (View Valtrex Review and Valtrex Label ), AMBIEN (View Ambien Review and Ambien Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

4724334-6 | Diverticulitis, Pyrexia
on Jul 20, 2005 Female patient from UNITED STATES , 56 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriamycin (View Usage). Patient had the following side effects: diverticulitis, pyrexia. Adriamycin dosage: 80mg Q 21 Days Iv. During the same period patient was treated with CYTOXAN (1300 Mg Q 21 Days Iv) (View Cytoxan Review and Cytoxan Label ), TAXOTERE (122 Mg Q 21 D Iv) (View Taxotere Review and Taxotere Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), TYLOX (View Tylox Review and Tylox Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

4676517-1 | Palmar-plantar Erythrodysaesthesia Syndrome
on May 26, 2005 Female patient from , weighting 216.0 lb, was treated with Adriamycin (View Usage). After Adriamycin was administered, patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome. Adriamycin dosage: 60 Mg/m2 Iv. During the same period patient was treated with CYTOXAN (600 Mg/m2 Iv) (View Cytoxan Review and Cytoxan Label ).

4639928-6 | Infusion Related Reaction, Urticaria
Patient was taking Adriamycin (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, urticaria on Apr 15, 2005 from Additional patient health information: Female patient , weighting 160.7 lb, was diagnosed with breast cancer (What is breast cancer?) and. Adriamycin dosage: 107 Mg Iv.